event tracking

Research

523 results.

September 20, 2020 International Linked Clinical Trials strategic funding for Parkinson's now worth US$6.75 million

LONDON (Sept. 21, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The…

September 20, 2020 University of Minnesota, Van Andel Institute earn $6M to study aging’s role in Parkinson’s

GRAND RAPIDS, Mich. (Sept. 21, 2020) — A collaborative team between the University of Minnesota Medical School and Van Andel Institute (VAI) will soon begin…

September 16, 2020 Van Andel Institute Graduate School student Maggie Chassé earns prestigious National Cancer Institute award

GRAND RAPIDS, Mich. (Sept. 17, 2020) — Van Andel Institute Graduate School student Maggie Chassé has earned a Predoctoral to Postdoctoral Fellow Transition Award from…

September 16, 2020 Searching for new ways to treat a rare childhood cancer

In summer 2020, Van Andel Institute Graduate School Ph.D. candidate Maggie Chassé earned a prestigious Predoctoral to Postdoctoral Fellow Transition Award, also known as the…

September 15, 2020 Graduate student spotlight: Investigating a cancer linked to a rare genetic disorder

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month features Lauren McGee, a student in the lab of Dr.…

September 14, 2020 Van Andel Institute to serve as Cancer MoonshotSM Biorepository

GRAND RAPIDS, Mich. (September 15, 2020) — Van Andel Institute’s Biorepository has been awarded a $2.7 million, two-year subcontract from the Frederick National Laboratory for…

August 30, 2020 Van Andel Institute remembers Dr. Viviane Labrie

The Institute mourns the loss of Associate Professor Dr. Viviane Labrie, who unexpectedly passed away August 21. Dr. Labrie was an imaginative, creative scientist. Her…

August 16, 2020 Switching off ‘master regulator’ may shield the brain from Parkinson’s-related damage

GRAND RAPIDS, Mich. (August 17, 2020) — Switching off a molecular “master regulator” may protect the brain from inflammatory damage and neurodegeneration in Parkinson’s disease,…